Incidence and sexual risk factors of cytomegalovirus seroconversion in HIV-infected subjects

被引:25
|
作者
Robain, M
Carré, N
Dussaix, E
Salmon-Ceron, D
Meyer, L
机构
[1] Hop Kremlin Bicetre, INSERM 292, Dept Publ Hlth Epidemiol Human Reprod, F-94276 Le Kremlin Bicetre, France
[2] Hop Paul Brousse, Dept Virol, Villejuif, France
[3] Hop Cochin, Dept Infect Dis, Paris, France
关键词
D O I
10.1097/00007435-199810000-00006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Data on incidence of cytomegalovirus (CMV) seroconversion in HIV-infected (HIV(+)) subjects was sparse. Goal: To determine the incidence of CMV seroconversion in sexually active HIV(+) subjects and sexual factors associated with CMV seroconversion. Study design: One hundred eighty four persons not infected by CMV at enrollment in a cohort of HIV(+) persons were studied. A case-control study within the cohort was conducted to determine the effect of sexual behavior in the 6 months prior to CMV seroconversion. Thirty seven cases of CMV seroconversion were compared with 136 controls. Results: The overall incidence of CMV seroconversion was 9.18 per 100 person-years (95% confidence interval (CI), 6.67-12.28) and was particularly high among homosexual men. After adjustment for age, socio-professional category, sexual orientation, and casual sex, the risk of CMV seroconversion was higher in subjects who never used condoms than in those who used them systematically (adjusted odds ratio (OR) 3.37; 95% CI, 1.05-11.00). Conclusions: In addition to the need to protect their sexual partners from HIV infection, HIV(+) subjects free of CMV infection should use condoms to avoid CMV infection and its complications.
引用
收藏
页码:476 / 480
页数:5
相关论文
共 50 条
  • [1] SYPHILITIC HEPATITIS IN A COHORT OF HIV-INFECTED SUBJECTS: INCIDENCE AND RISK FACTORS
    Rossotti, R.
    Molteni, C.
    Bonfanti, P.
    Orani, A.
    [J]. INFECTION, 2011, 39 : S79 - S80
  • [2] Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy
    Casado, JL
    Arrizabalaga, J
    Montes, M
    Martí-Belda, P
    Tural, C
    Pinilla, J
    Gutierrez, C
    Portu, J
    Schuurman, R
    Aguirrebengoa, K
    [J]. AIDS, 1999, 13 (12) : 1497 - 1502
  • [3] Diagnosis and clinical characterization of cytomegalovirus infection in HIV-infected subjects
    Shakhgildyan, VI
    Kravchenko, AV
    Shipulina, OY
    Marchenko, NR
    Ermak, TN
    Yurin, OG
    Stakhanova, VM
    Parkhomenko, YG
    Karazhas, NV
    Evseeva, LF
    Gruzdev, BM
    Pokrovsky, VV
    [J]. TERAPEVTICHESKII ARKHIV, 1996, 68 (04): : 65 - 68
  • [4] Incidence of presumed cytomegalovirus retinitis in HIV-infected pediatric patients
    Du, LT
    Coats, DK
    Kline, MW
    Rosenblatt, HM
    Bohannon, B
    Contant, CF
    Zhong, YX
    Brown, B
    Steinkuller, PG
    Paysse, EA
    [J]. JOURNAL OF AAPOS, 1999, 3 (04): : 245 - 249
  • [5] Kaposi Sarcoma Incidence and Survival Among HIV-Infected Homosexual Men After HIV Seroconversion
    Lodi, Sara
    Guiguet, Marguerite
    Costagliola, Dominique
    Fisher, Martin
    de Luca, Andrea
    Porter, Kholoud
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (11) : 784 - 792
  • [6] The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era
    Burkey, M. D.
    Wilson, L. E.
    Moore, R. D.
    Lucas, G. M.
    Francis, J.
    Gebo, K. A.
    [J]. HIV MEDICINE, 2008, 9 (10) : 858 - 862
  • [7] Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania
    Said, K.
    Verver, S.
    Kalingonji, A.
    Lwilla, F.
    Mkopi, A.
    Charalambous, S.
    Reither, K.
    [J]. AFRICAN HEALTH SCIENCES, 2017, 17 (01) : 208 - 215
  • [8] Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes
    Haines, Charles F.
    Moore, Richard D.
    Bartlett, John G.
    Sears, Cynthia L.
    Cosgrove, Sara E.
    Carroll, Karen
    Gebo, Kelly A.
    [J]. AIDS, 2013, 27 (17) : 2799 - 2807
  • [9] ASYMPTOMATIC TOXOPLASMOSIS SEROCONVERSION IN AN HIV-INFECTED PATIENT
    PARIS, L
    CARRIERE, J
    NIEL, G
    DANIS, M
    GENTILINI, M
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 (05): : 643 - 644
  • [10] Cardiovascular risk due to lipoprotein (a) in HIV-infected subjects
    Richter, W. O.
    Schnaitmann, E.
    Trein, A.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 399 - 399